Contract 36F79724D0178
Melinta Therapeutics, Llc · Department Of Veterans Affairs · August 13, 2024
Melinta Therapeutics, Llc was awarded a federal contract by Department Of Veterans Affairs on August 13, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 8 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 30, 2026. If all options are exercised, the contract could reach $9.66 million.
Contract details
- PIID
- 36F79724D0178
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 13, 2024
- Latest action
- March 30, 2026
Description
DELETION
Modification timeline
-
March 30, 2026Mod P00008$0
-
March 18, 2026Mod P00007SIGNATORY AUTHORITY FORM CHANGE$0
-
November 13, 2025Mod P000062026 PUBLIC LAW PRICING UPDATES$0
-
November 3, 2025Mod P00005ADMINISTRATIVE CHANGE- SIGNATORY AUTHORITY AND POINT OF CONTACT$0
-
October 30, 2025Mod P00004BUSINESS SIZE RE-REPRESENTATION$0
-
June 11, 2025Mod P00003$0
-
June 10, 2025Mod P00002ADMINISTRATIVE CHANGE-PHARMACEUTICAL PRIME VENDOR TRUE$0
-
November 26, 2024Mod P00001PUBLIC LAW 2025 PRICING UPDATES$0
-
August 13, 2024Base award65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79724D0178?
Contract 36F79724D0178 is a federal contract awarded to Melinta Therapeutics, Llc by Department Of Veterans Affairs on August 13, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 8 times since the base award.
Who won contract 36F79724D0178?
Melinta Therapeutics, Llc won contract 36F79724D0178 from Department Of Veterans Affairs.
How much is contract 36F79724D0178 worth?
Contract 36F79724D0178 has obligated $0 to date but carries a potential ceiling of $9.66 million if fully funded and all options are exercised.